<p><strong>在本次免費網絡研討會中，深入瞭解早期協議決策如何直接影響供應規劃和隨機化及試驗供應管理（RTSM）配置。與會者將學習哪些協議部分需要更深入的操作審查以及原因。特邀講者將討論導致下游供應問題的常見假設以及如何避免這些問題。與會者將接觸到實用的問題和框架，以支持更強的研究啓動基礎。</strong></p>
<p>, /PRNewswire/ -- 早期協議設計決策對臨牀供應策略和隨機化及試驗供應管理（RTSM）績效具有重要的操作性後果。許多在研究中出現的問題源於在入組開始之前做出的假設、定義或設計選擇。本次網絡研討會彙集了來自 Converge、4G Clinical 和 Third Arc Bio 的專家，從多個操作角度審視這些早期決策，提供通常只有通過與經驗豐富的合作伙伴直接合作才能獲得的見解。</p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>www.4gclinical.com</p>
<p>以協議場景為基礎，討論將探討設計選擇如何影響預測方法、試劑盒架構、過期策略、池化模型、補給邏輯和更廣泛的 RTSM 行為。通過集體分析這些因素，專家小組將揭示不同利益相關者如何解讀相同的協議，最常出現的不一致之處，以及如何通過早期明確性防止下游複雜性。</p>
<p>此次討論旨在分享專家思考，而非案例研究或產品演示。重點是高級供應專業人士、RTSM 專家和研究團隊在評估新協議時始終優先考慮的實際考慮因素。與會者將更清晰地瞭解協議中哪些元素值得更深入的操作審查，如何避免引入風險的假設，以及促進更強跨職能對齊的問題類型。</p>
<p>會議將以簡要展望新興技術（包括人工智能工具）如何影響未來協議開發和供應規劃結束。這為小組的實用指導增添了一個審慎的前瞻性視角。</p>
<p>由 4G Clinical、Converge 和一位贊助商代表共同主辦的本次會議彙集了最直接影響試驗準備的操作觀點，為與會者提供了一個紮實而多面的視角，瞭解如何設計真正支持執行的協議。</p>
<p>註冊參加本次網絡研討會，瞭解如何從操作角度評估協議，並從一開始就加強臨牀供應規劃和 RTSM 準備。</p>
<p>加入 Jennifer Cobb Foulkes（Converge Consulting 臨牀供應鏈服務實踐總監）、Jennifer Teti（Third Arc Bio 臨牀運營副總裁）、Savannah Holt（4G Clinical 交付運營經理）和 Jonathan Pritchard（主持人，4G Clinical 產品戰略總監），參加 2026 年 2 月 11 日星期三東部時間下午 1 點（太平洋時間上午 10 點）的直播網絡研討會。</p>
<p>有關更多信息或註冊此活動，請訪問早期協議設計如何塑造供應策略和 RTSM 準備。</p>
<p><strong>關於 XTALKS</strong></p>
<p>Xtalks — 生命科學社區™ 賦能製藥、生物技術、醫療技術、醫療保健和研究領域的專業人士，提供可信的知識和協作見解，推動行業向前發展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新聞、特寫文章、網絡研討會、播客、視頻、專家訪談、精心策劃的工作機會等，旨在支持在快速發展的行業中做出明智的決策。</p>
<p>每年，成千上萬的專業人士依賴 Xtalks 獲取及時的信息、同行觀點和行業思想領導力。加入我們的生命科學社區，保持信息靈通、互聯互通，併為未來做好準備。</p>
<p>要了解有關 Xtalks 的更多信息，請訪問 www.xtalks.com</p>
<p>有關與 Xtalks 合作舉辦網絡研討會的信息，請訪問 https://xtalks.com/partner-with-us/</p>
<p>聯繫方式：</p>
<p>Vera Kovacevic</p>
<p>電話：+1 (416) 977-6555 x371</p>
<p>電子郵件：[email protected]</p>
<p>來源：Xtalks</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Tlk2NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwODMwUFJfTkVXU19VU1BSX19fX19OWTY3MDY0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Tlk2NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwODMwUFJfTkVXU19VU1BSX19fX19OWTY3MDY0"/></p>

<p>一場題為 “早期協議設計如何影響供應策略和隨機化與試驗供應管理（RTSM）準備” 的免費網絡研討會將於 2026 年 2 月 11 日下午 1 點（東部標準時間）舉行。此次會議將探討早期協議設計對臨牀供應策略以及隨機化和試驗供應管理（RTSM）的影響。來自 Converge、4G Clinical 和 Third Arc Bio 的專家將討論運營考慮因素、導致供應問題的常見假設，以及新興技術對未來協議開發的影響。與會者將獲得有效供應規劃和 RTSM 準備的見解</p>

<p><strong>In this free webinar, gain insight into how early protocol decisions directly influence supply planning and RTSM configuration. Attendees will learn which protocol sections warrant deeper operational scrutiny and why. The featured speakers will discuss common assumptions that lead to downstream supply issues and how to avoid them. Attendees will be introduced to practical questions and frameworks to support stronger study start-up foundations.</strong></p>
<div class="lb-trans"><p><strong>在本次免費網絡研討會中，深入瞭解早期協議決策如何直接影響供應規劃和隨機化及試驗供應管理（RTSM）配置。與會者將學習哪些協議部分需要更深入的操作審查以及原因。特邀講者將討論導致下游供應問題的常見假設以及如何避免這些問題。與會者將接觸到實用的問題和框架，以支持更強的研究啓動基礎。</strong></p>
</div><p>, /PRNewswire/ -- Early protocol design decisions carry significant operational consequences for clinical supply strategy and randomization and trial supply management (RTSM) performance. Many issues that emerge mid-study originate in assumptions, definitions or design choices made long before enrollment begins. This webinar brings together specialists from Converge, 4G Clinical and Third Arc Bio to examine these early decisions from multiple operational perspectives, offering the type of insight typically gained only through direct collaboration with experienced partners.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 早期協議設計決策對臨牀供應策略和隨機化及試驗供應管理（RTSM）績效具有重要的操作性後果。許多在研究中出現的問題源於在入組開始之前做出的假設、定義或設計選擇。本次網絡研討會彙集了來自 Converge、4G Clinical 和 Third Arc Bio 的專家，從多個操作角度審視這些早期決策，提供通常只有通過與經驗豐富的合作伙伴直接合作才能獲得的見解。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>www.4gclinical.com</p>
<div class="lb-trans"><p>www.4gclinical.com</p>
</div><p>Using protocol scenario as the anchor, the discussion will explore how design choices influence forecasting approaches, kit architecture, expiry strategy, pooling models, resupply logic and broader RTSM behavior. By analyzing these factors collectively, the panel will reveal how different stakeholders interpret the same protocol, where misalignment most often occurs and how early clarity can prevent downstream complications.</p>
<div class="lb-trans"><p>以協議場景為基礎，討論將探討設計選擇如何影響預測方法、試劑盒架構、過期策略、池化模型、補給邏輯和更廣泛的 RTSM 行為。通過集體分析這些因素，專家小組將揭示不同利益相關者如何解讀相同的協議，最常出現的不一致之處，以及如何通過早期明確性防止下游複雜性。</p>
</div><p>The conversation is designed to share expert thinking rather than case studies or product walk-throughs. The focus is on the practical considerations that senior supply professionals, RTSM specialists and study teams consistently prioritize when evaluating a new protocol. Attendees will gain a clearer sense of which elements of the protocol deserve deeper operational scrutiny, how to avoid assumptions that introduce risk and the types of questions that promote stronger cross-functional alignment from the outset.</p>
<div class="lb-trans"><p>此次討論旨在分享專家思考，而非案例研究或產品演示。重點是高級供應專業人士、RTSM 專家和研究團隊在評估新協議時始終優先考慮的實際考慮因素。與會者將更清晰地瞭解協議中哪些元素值得更深入的操作審查，如何避免引入風險的假設，以及促進更強跨職能對齊的問題類型。</p>
</div><p>The session will close with a brief look forward at how emerging technologies, including AI-enabled tools, may influence future protocol development and supply planning. This adds a measured horizon-scanning perspective, complementing the panel's practical guidance.</p>
<div class="lb-trans"><p>會議將以簡要展望新興技術（包括人工智能工具）如何影響未來協議開發和供應規劃結束。這為小組的實用指導增添了一個審慎的前瞻性視角。</p>
</div><p>Delivered jointly by 4G Clinical, Converge and a sponsor representative, this session brings together the operational viewpoints that most directly shape trial readiness, offering attendees a grounded and multifaceted view of how to design protocols that truly support execution.</p>
<div class="lb-trans"><p>由 4G Clinical、Converge 和一位贊助商代表共同主辦的本次會議彙集了最直接影響試驗準備的操作觀點，為與會者提供了一個紮實而多面的視角，瞭解如何設計真正支持執行的協議。</p>
</div><p>Register for this webinar to learn how to assess protocols through an operational lens and strengthen both clinical supply planning and RTSM readiness from the start.</p>
<div class="lb-trans"><p>註冊參加本次網絡研討會，瞭解如何從操作角度評估協議，並從一開始就加強臨牀供應規劃和 RTSM 準備。</p>
</div><p>Join Jennifer Cobb Foulkes, Practice Director, Clinical Supply Chain Services, Converge Consulting; Jennifer Teti, Vice President, Clinical Operations, Third Arc Bio; Savannah Holt, Delivery Operations Manager, 4G Clinical; and Jonathan Pritchard (Moderator), Director of Product Strategy, 4G Clinical, for the live webinar on Wednesday, February 11, 2026, at 1pm EST (10am PST).</p>
<div class="lb-trans"><p>加入 Jennifer Cobb Foulkes（Converge Consulting 臨牀供應鏈服務實踐總監）、Jennifer Teti（Third Arc Bio 臨牀運營副總裁）、Savannah Holt（4G Clinical 交付運營經理）和 Jonathan Pritchard（主持人，4G Clinical 產品戰略總監），參加 2026 年 2 月 11 日星期三東部時間下午 1 點（太平洋時間上午 10 點）的直播網絡研討會。</p>
</div><p>For more information, or to register for this event, visit How Early Protocol Design Shapes Supply Strategy and RTSM Readiness.</p>
<div class="lb-trans"><p>有關更多信息或註冊此活動，請訪問早期協議設計如何塑造供應策略和 RTSM 準備。</p>
</div><p><strong>ABOUT XTALKS</strong></p>
<div class="lb-trans"><p><strong>關於 XTALKS</strong></p>
</div><p>Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.</p>
<div class="lb-trans"><p>Xtalks — 生命科學社區™ 賦能製藥、生物技術、醫療技術、醫療保健和研究領域的專業人士，提供可信的知識和協作見解，推動行業向前發展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新聞、特寫文章、網絡研討會、播客、視頻、專家訪談、精心策劃的工作機會等，旨在支持在快速發展的行業中做出明智的決策。</p>
</div><p>Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.</p>
<div class="lb-trans"><p>每年，成千上萬的專業人士依賴 Xtalks 獲取及時的信息、同行觀點和行業思想領導力。加入我們的生命科學社區，保持信息靈通、互聯互通，併為未來做好準備。</p>
</div><p>To learn more about Xtalks, visit www.xtalks.com</p>
<div class="lb-trans"><p>要了解有關 Xtalks 的更多信息，請訪問 www.xtalks.com</p>
</div><p>For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/</p>
<div class="lb-trans"><p>有關與 Xtalks 合作舉辦網絡研討會的信息，請訪問 https://xtalks.com/partner-with-us/</p>
</div><p>Contact:</p>
<div class="lb-trans"><p>聯繫方式：</p>
</div><p>Vera Kovacevic</p>
<div class="lb-trans"><p>Vera Kovacevic</p>
</div><p>Tel: +1 (416) 977-6555 x371</p>
<div class="lb-trans"><p>電話：+1 (416) 977-6555 x371</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>電子郵件：[email protected]</p>
</div><p>SOURCE Xtalks</p>
<div class="lb-trans"><p>來源：Xtalks</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Tlk2NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwODMwUFJfTkVXU19VU1BSX19fX19OWTY3MDY0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY67064&amp;Transmission_Id=202601210830PR_NEWS_USPR_____NY67064&amp;DateId=20260121"/></p>

Xtalks 即將舉辦的網絡研討會：早期協議設計如何影響供應策略和 RTSM 的準備